LIVN News and Press, LivaNova PLC From 11/01/23

2023-11-01 13:26:04 ET LivaNova PLC (LIVN) Q3 2023 Earnings Conference Call November 1, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development & IT Bill Cozy - Chairman and Interim Chief Executive Officer Alex Shvart...

Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...

2023-11-01 06:10:11 ET More on LivaNova PLC LivaNova: Selloff Corroborated By Long-Term Economic Prospects LivaNova gains regulatory nod for blood monitoring device Seeking Alpha’s Quant Rating on LivaNova PLC Historical earnings data for LivaNova PLC ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended September 30, 2023 and raised full-year 2023 revenue and adjusted diluted earnings per share guidance. Financial Summary and Highlights 1 Third-quarter reve...

LivaNova PLC (LIVN) is expected to report $0.62 for Q3 2023

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Bill Kozy, Interim Chief Executive Officer and Board Chair of LivaNova, will present a general business update during fireside chats at two healthcare conferences in New York in November: Stifel Health...

2023-10-16 21:50:24 ET Summary Investors continue to sell shares of LivaNova PLC, with the stock down 17-18% since its Q2 FY'23 results. The company's latest numbers showed positive growth, but it is uncertainty remains on its long-term competitive position. The market's expec...

Long-time Director Andrea Saia to retire from the Board LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced its Board of Directors has appointed J. Christopher Barry to the Board, effective today. Barry will serve on the Audit and Compliance Committee. An...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Marco Dolci intends to retire as President of the Cardiopulmonary (CP) Business Unit (BU) by December 31, 2023. Dolci will continue in his role and support the transition of responsibilities through the...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2023 results on Wednesday, November 1, 2023 at 12 p.m. London time (8 a.m. Eastern Time). The Company will release its third-quarter 2023 results prior to the call. ...